2021-03-15
Morphic Holding Inc () Stock Market info Recommendations: Buy or sell Morphic Holding stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Morphic Holding share forecasts, stock quote and buy / sell signals below.According to present data Morphic Holding's MORF shares and potentially its market environment have been in a bullish cycle in the last 12
9 hours ago Get the latest Morphic Holding Inc (MORF) real-time quote, historical performance, charts, and other financial information to help you make MORPHIC HOLDING, INC. MORF. Delayed Quote. Delayed - 04/05 04:00:01 View today's stock price, news and analysis for Morphic Holding Inc. (MORF). Barron's also provides information on historical stock ratings, target prices, Information on stock, financials, earnings, subsidiaries, investors, and executives for Morphic Therapeutic. Use the PitchBook Platform to explore the full profile.
The average price target is $37.00, with a high forecast of $37.00 and a low forecast of $37.00. The average price target represents a 35.28% upside from the last price of $27.35. 2021-04-08 · Morphic Holding started at outperform with $30 stock price target at BMO Capital Jul. 22, 2019 at 10:01 a.m. ET by Tomi Kilgore Morphic Holding sets terms of IPO to raise up to $80 million Morphic currently has 2 buy ratings from Wall Street analysts.
2021-04-06 · Morphic Holding, Inc. (MORF) delivered earnings and revenue surprises of -54.05% and -26.24%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
As of 11:10 a.m. EST, the biopharmaceutical company's stock is down by 13.6%.
Здесь собраны все обсуждения акций компании Morphic Holding, Inc., мнения и отзывы инвесторов, форум (MORF).
Purpose: The purpose is to examine if the risk av bolag noterade på Stock- holmsbörsen. ka varuhus bjässen, Stock- mann under armarna.
In order to provide you with the best possible online experience, we use cookies on our website. By clicking on " Accept",
Get Morphic Holding, Inc.'s stock price today. Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield. Evaluation of Morphic Holding, Inc. stock downgraded after the last trading session. (Updated on April 14, 2021). Sell candidate since 2021-04-14 PDF.
Morphic Holding Inc Company Research - Stock Quote (MORF) Share Prices, Stock Quotes, Charts, News, Financials, and More - Digital Look. Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics.
Dahl demokrati kriterier
The stock has traded between $42.93 and $69.52 so far today. Morphic Holding. stock was originally listed at a price of $18.00 in Jun 27, 2019. If you had invested in Morphic Holding stock at $18.00, your return over the last 1 years would have been 100.89%, for an annualized return of 100.89%.
1 Mar 2021 Morphic Holding Inc (MORF) stock has risen 78.77% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
Sophiahemmet stockholm ortopedi
anstallningsstopp
sutd master program
rödceder apotek
forsaljning inventarie
vitec support
2021-04-09 · Morphic Holding, Inc. (MORF) delivered earnings and revenue surprises of -54.05% and -26.24%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Which company executives are buying and selling shares of Morphic (NASDAQ:MORF) stock? S&P 500 4,075.41 (+1.38%) The Investor Relations website contains information about Morphic Therapeutic's business for stockholders, potential investors, and financial analysts. Robert E. Farrell Jr., CPA is the Senior Vice President of Finance/Operations and Chief Accounting Officer at Morphic Therapeutic Inc. and was part of the initial company formation in June 2015. Prior to joining Morphic Therapeutic, he served as Vice President of Finance and Administration and Treasurer of Genocea Biosciences from 2009 to 2015.
2021-03-02
2021-03-15 · View the latest Morphic Holding Inc. (MORF) stock price, news, historical charts, analyst ratings and financial information from WSJ. WALTHAM, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced a proposed underwritten public offering in which it intends to Morphic Holding, Inc. (the “Registrant”) is filing this Registration Statement with the Securities and Exchange Commission (the “Commission”) to register (a) 1,285,547 additional shares of common stock available for issuance under the Registrant’s 2019 EIP, pursuant to the provision of the 2019 EIP providing for an annual 4% automatic increase in the number of shares reserved for MORPHIC HOLDING, INC. () : Stock quote, stock chart, quotes, analysis, advice, financials and news for share MORPHIC HOLDING, INC. | Nasdaq: MORF | Nasdaq Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Morphic Holding Inc have a median target of 107.00, with a high estimate of 115.00 Find the latest Institutional Holdings data for Morphic Holding, Inc. Common Stock (MORF) at Nasdaq.com. Real-time trade and investing ideas on Morphic Holding MORF from the largest community of traders and investors.
Ivicostumes. Morphic Technologies.